首页> 外文期刊>European urology >Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium
【24h】

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium

机译:使用体外循环和肾细胞癌侵袭的肾细胞癌侵袭肾细胞癌的围手术和肿瘤血栓切除术的围手术和肿瘤血栓切除术的围攻和肿瘤血栓切除术治疗Supradmatmation Derma Cava和/或右心房

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Radical nephrectomy (RN) and caval thrombectomy (CT) for renal cell carcinoma, with extracorporeal circulation (ECC) and deep hypothermic circulatory arrest (DHCA) is a challenging surgical approach.& para;& para;Objective: To assess peri-operative and oncologic outcomes of renal cell carcinoma patients treated with RN and CT, using ECC and DHCA.& para;& para;Design, setting, and participants: We retrospectively evaluated 46 patients who underwent RN and CT using ECC and DHCA.& para;& para;Surgical procedure: After retroperitoneal nodal dissection and RN, a cardiopulmonary bypass was placed and DHCA achieved. A combined approach through the abdomen and the thorax was described.& para;& para;Measurements: Perioperative and long-term survival outcomes were reported.& para;& para;Results and limitations: Median operative time and length of hospital stay were 545 min and 22 d. Overall, 33 patients (72%) did not require any additional interventional or surgical treatment. Thirty-day and 90-d mortality were 11% (5/46) and 15% (7/46). The 1-yr, 2-yr, and 3-yr cancer specific mortality (CSM)-free survival rates were 77%, 62%, and 56%, respectively. After stratification, according to metastatic status at diagnosis, CSM-free survival rates were significantly lower for cM1 patients compared with cM0 patients (1-yr 46% vs 93%, 2-yr 23% vs 81%, 3-yr 23% vs 73%, p 0.01). Our study is limited by its retrospective and uncomparative nature.& para;& para;Conclusions: RN with CT using ECC and DHCA is a challenging procedure which requires a dedicated multidisciplinary working team to minimise complications and maximise patients' outcomes.& para;& para;Patient summary: Patients with kidney cancer and a thrombus within the inferior vena cava, which reaches above the diaphragm, can be treated with surgery. However, this kind of surgical treatment is challenging and requires a dedicated multidisciplinary team in order to accomplish the task. (C) 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.
机译:背景:肾细胞癌的根治性肾切除术(RN)和脉血栓切除术(CT),具有体外循环(ECC)和深度低温循环骤停(DHCA)是一个挑战的手术方法。&律师;&段;目标:评估围住使用ECC和DHCA治疗肾细胞癌患者的手术和肿瘤结果。&PARA;&PARA;设计,设置和参与者:我们回顾性评估了使用ECC和DHCA接受RN和CT的46名患者。&PARA ;&para;手术程序:腹膜后胚芽解剖和RN后,放置了一种心肺旁路,达到了DHCA。描述了通过腹部和胸腔的组合方法。&para;&para;测量:围手术期和长期存活结果。&para;&para;结果和限制:中位数手术时间和住院时间长度为545分钟和22天。总体而言,33名患者(72%)不需要任何额外的介入或手术治疗。 30天和90级死亡率为11%(5/46)和15%(7/46)。 1 yr,2-yr和3 yr癌症特异性死亡率分别为77%,62%和56%。在分层后,根据诊断的转移状态,对于CM1患者,CM1患者的无CSM存活率显着降低(1-YR 46%VS 93%,2-YR 23%Vs 81%,3 yr 23%Vs 73%,p <0.01)。我们的研究受到其回顾性和不验的性质的限制。&para;&para;结论:使用CT使用ECC和DHCA是一个具有挑战性的程序,需要专门的多学科工作团队,以最大限度地减少复杂性并最大限度地提高患者的结果。&患者概要:肾癌患者和下腔静脉内的血栓,可以用手术治疗。然而,这种外科治疗是挑战性的,需要一个专门的多学科团队,以完成任务。 (c)2017年欧洲泌尿外科协会。 elsevier b.v出版。保留所有权利。

著录项

  • 来源
    《European urology》 |2018年第5期|共7页
  • 作者单位

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Pathol Milan Italy;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Pathol Milan Italy;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Cardiac Surg Milan Italy;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

    Univ Vita Salute San Raffaele IRCCS San Raffaele Sci Inst Unit Urol Via Olgettina 60 I-20132;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 泌尿科学(泌尿生殖系疾病);
  • 关键词

    Renal cell carcinoma; Thrombus; Caval thrombectomy; Extracorporeal circulation; Hypothermic circulatory arrest; Atrium;

    机译:肾细胞癌;血栓;肿瘤血栓切除术;体外循环;低温循环骤停;心房;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号